论文信息 - Efficacy and safety of tailored and dose‐dense adjuvant chemotherapy and trastuzumab for resected HER2‐positive breast cancer: Results from the phase 3 PANTHER trial - 字舞流文

Efficacy and safety of tailored and dose‐dense adjuvant chemotherapy and trastuzumab for resected HER2‐positive breast cancer: Results from the phase 3 PANTHER trial

R. Greil | J. Bergh | P. Malmström | M. Gnant | S. Loibl | M. Untch | N. Bengtsson | G. Steger | H. Johansson | T. Foukakis | V. Moebus | L. Hübbert | A. Matikas | E. Hedayati | A. Papakonstantinou | M. Hellström